Pacira BioSciences (PCRX) Shares Outstanding (Entity) (2010 - 2026)
Pacira BioSciences (PCRX) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 834.66 Mn |
| 10 | Pacira BioSciences | 943.93 Mn | 692.90 Mn | 148.24 Mn | 39.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.46 Mn |
| Mar 31, 2026 | 48.33 Mn |
| Dec 31, 2025 | 47.89 Mn |
| Sep 30, 2025 | 47.74 Mn |
| Jun 30, 2025 | 47.69 Mn |
| Mar 31, 2025 | 47.12 Mn |
| Dec 31, 2024 | 47.08 Mn |
| Sep 30, 2024 | 46.99 Mn |
| Jun 30, 2024 | 46.95 Mn |
| Mar 31, 2024 | 46.52 Mn |
| Dec 31, 2023 | 46.48 Mn |
| Sep 30, 2023 | 46.43 Mn |
| Jun 30, 2023 | 46.41 Mn |
| Mar 31, 2023 | 45.97 Mn |
| Dec 31, 2022 | 45.93 Mn |
| Sep 30, 2022 | 45.86 Mn |
| Jun 30, 2022 | 45.80 Mn |
| Mar 31, 2022 | 45.06 Mn |
| Dec 31, 2021 | 44.73 Mn |
| Sep 30, 2021 | 44.52 Mn |